Development and Biological Evaluation of Novel Anticancer Drugs
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: 31 March 2026
Special Issue Editors
Interests: metformin; anticancer; pharmaceutical evaluation
Interests: anticancer drugs
Interests: pharmacokinetics; compartmental analysis; mathematical models for clinical trials; anticanacer therapies
Interests: nanomedicines; drug delivery systems; biologics; combination drugs; multifunctional nanocarriers; biomaterials surface modification; nanocrystals; solid form screening; cocrystals; material analysis; preformulation; preclinical drug development screens; microfluidics; anticancer drug delivery systems
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear colleagues,
The anticancer effects of repurposed drugs and well-established non-oncologic drugs are an emerging field in the investigation of novel anticancer drugs. Sarcoma models are of fundamental importance in cancer treatment research due to the multiple pathological and clinical entities, resistance to current therapies, and high mortality attributed to these malignancies. Despite treatment protocols that combine chemotherapy, including methotrexate, cisplatin, doxorubicin, and ifosfamide, surgery, and radiotherapy, the 5-year survival rate for patients diagnosed with sarcoma is still not very high. Current treatment strategies for sarcomas, including fibrosarcoma, are associated with significant side effects, and there have been no significant improvements in prognosis in recent decades. Therefore, there is a need for improved, repurposed, and novel nontoxic therapies for the treatment of sarcoma and fibrosarcoma, as well as other types of cancer. This Special Issue will be devoted to investigations of novel and repurposed drugs that have significant new results in cancer treatment. We are interested in papers that provide examples of novel and repurposed uses of drugs that are new compared to well-established protocols in cancer treatment. This field of interest can include interactions of different drugs, reviews and meta-analyses, original research, and the use of software to determine desirable candidate molecules and drugs for repurposing.
Dr. Kosta Popović
Dr. Dušica Popović
Dr. Jovan K. Popović
Dr. Sabiruddin Mirza
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Anticancer effects
- Repurposed drugs
- Novel anticancer drugs
- Sarcoma
- Nontoxic anticancer treatment
- Fibrosarcoma
- Oncology
- Cancer
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
